The CHORAL Flow Study

NCT04073134 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Funding withdrawn

Conditions

Coronary Artery Disease
Atherosclerosis
Hyperlipidemias

Interventions

BIOLOGICAL: Evolocumab
DRUG: Placebo

Sponsor

Imperial College London